Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,263 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Recruiting

Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial

NCT05327010

Conditions
Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +5 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
View all 36 locations
View Trial Details
Recruiting

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

NCT06863272

Conditions
Castration-Resistant Prostatic Cancer, Genital Diseases, Genital Diseases, Male, +14 more
Locations
  • UCLA Hematology & Oncology ( Site 0003) Los Angeles, California, United States
  • University of California-Irvine Medical Center ( Site 0016) Orange, California, United States
  • UCSF Medical Center at Mission Bay ( Site 0034) San Francisco, California, United States
  • MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026) Washington D.C., District of Columbia, United States
View all 82 locations
View Trial Details
Recruiting

A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

NCT07030712

Conditions
Metastatic Neoplasm, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Northwestern University ( Site 0101) Chicago, Illinois, United States
  • Houston Methodist Hospital ( Site 0103) Houston, Texas, United States
  • Rambam Health Care Campus ( Site 0201) Haifa, Israel
  • Sheba Medical Center ( Site 0200) Ramat Gan, Israel
View Trial Details
Recruiting

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

NCT05875168

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • Rhode Island Hospital Providence, Rhode Island, United States
  • University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
View all 33 locations
View Trial Details
Recruiting

Decision Support Tool for Patients With Advanced Breast Cancer

NCT07635147

Conditions
Advanced Breast Cancer, Behavior, Breast Cancer Metastatic, +13 more
Locations
  • NewYork-Presbyterian Brooklyn Methodist Hospital Brooklyn, New York, United States
  • NewYork-Presbyterian David H. Koch Center New York, United States
  • NewYork-Presbyterian Medical Group Queens New York, United States
View Trial Details
Recruiting

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

NCT07028489

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Pacific Cancer Care Monterey, California, United States
  • Torrance Memorial Physician Network-Cancer Care Torrance, California, United States
  • John Muir Health Walnut Creek, California, United States
  • Bayhealth Cancer Center- Kent Dover, Delaware, United States
View Trial Details

Related conditions